Gilead Sciences Inc. will allow some of its AIDS drugs to be made by generic manufacturers, potentially increasing their availability in poor countries, particularly in Africa, officials said Tuesday.
In the first deal of its kind, the pharmaceutical company has agreed to allow four of its AIDS drugs to be made by generic drug companies at a cheaper cost in return for a small proportion of royalties, United Nations health officials said.
Most of the 33 million people worldwide who have HIV, the virus that causes AIDS, live in Africa. One of the drugs will also be used to treat people with hepatitis.
The deal was negotiated by the Medicines Patent Pool, part of a U.N.-led partnership that raises money for AIDS, tuberculosis and malaria by things like taxing airplane tickets. Among the partnership's 29 member countries, only Chile, France, Korea, Mali and Niger are actually implementing the airline tax.
"We will continue to work with Gilead and others to expand access to all people living with HIV in developing countries," said Ellen 't Hoen, executive director of the Medicines Patent Pool.
Gilead will receive from three to five percent royalties on its four drugs, which will be supplied to about 100 countries.
Until now, its drugs have been mainly sold in rich countries, and profits from the new deal are expected to be a tiny fraction of those Gilead gets from the West.
Typically, patients in poor countries have to wait for years until the patents expire on new drugs before they can be made more cheaply by generic companies.
Ranbaxy Laboratories recently entered into a deal with Gilead Sciences that will allow the Indian pharmaceuticals company to manufacture generic versions of three new HIV medications.
So good topic really i like any post talking about STD symptoms pictures and more , you shall search in Google and Wikipedia about that .... thanks a gain ,,,
ReplyDelete